BRITISH DIABETIC ASSOCIATION(THE)

Company number

00339181

Status

Active

Incorporation

1938-04-11

Last accounts made up

2024-12-31

Account category

GROUP

Primary SIC

86900

Hubs

UK Healthcare

Accounting basis

FRS 102

Reporting scope

Consolidated (group)

Auditor

Crowe UK LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“The Trustees therefore have a reasonable expectation that the charity has adequate resources to continue in operational existence for the foreseeable future, being at least 12 months from the date of approval of these financial statements and are not aware of any other material uncertainties which may adversely affect the organisation. Accordingly, the financial statements continue to be prepared on the going concern basis.”

Subsidiaries

• BDA Research Limited · 100% held · UK · did not carry out any business activity in the year
• Diabetes UK Services Limited · 100% held · UK · corporate sponsorship, running the lottery, sales of various seasonal goods including Christmas cards, and income from promotional activities

Significant events

• “alarming rise in the number of people under 40 developing type 2 diabetes, especially in those from Black and South Asian backgrounds and people in our most deprived communities”
• “annual UK healthcare cost of diabetes complications has topped £6 billion”
• “the start of our work to raise awareness of the stigma associated with diabetes, which really gained momentum when we invited people with diabetes to send us their day-to-day experiences of stigma”
• “launched the Western Diabetes Group in Northern Ireland”
• “launched the first UK funding schemes to support aspiring Black students in pursuing careers in diabetes research”
• “took our 'Reverse the Trend' report to Parliament, calling for government action to address the alarming rise in the number of people under 40 developing type 2 diabetes”
• “Midlands & East team launched a diabetes prevention and awareness initiative in partnership with medical devices and healthcare company Abbott”
• “a pilot in our South West and South Central region introduced a 'traffic light tool' to improve follow-up care for women with gestational diabetes”
• “Midlands & East team hosted the 13th annual Diabetes in Pregnancy UK Conference”
• “the Type 1 Diabetes Grand Challenge has invested over £23 million in 19 groundbreaking research projects”
• “£1.1 million allocated to three pioneering beta cell therapy projects for beta cell therapy projects”
• “launched two additional Live Well Hubs, increasing the total to five as part of a five-year project funded by the National Lottery Community Fund”
• “relaunched 'Your guide to type 2 diabetes', offering updated, user-centred content”
• “commissioned research from the York Health Economics Consortium, published in Diabetic Medicine Journal, to emphasise the seriousness of diabetes to political and NHS decision-makers”
• “partnered with Cornwall Integrated Care Board to pioneer diabetes super clinics”
• “partnered with the Black Men's Consortium to examine the policies, bureaucracies and power structures within the diabetes system”
• “TT1 Youth Teams have introduced the Tree of Life programme, a one-day wellbeing initiative designed to help young people reflect on their diabetes journey”
• “seven Young Leaders represented us at the Diabetes UK Professionals Conference”
• “invested £4 million into 17 new research projects, bringing the total value of our active grants to over £45 million”
• “successfully launched our new and improved Learning Zone, the charity's personalised online diabetes education service”
• “Online Community Forum continued to grow with over 4,500 new members joining”
• “Sheffield Diabetes UK Group hosted the impactful Diabetes and Me event, attended by 70 people seeking vital diabetes care, services, and support”
• “Bexley group raised over £2,000 through fundraising events”
• “Our 'A World Without Diabetes' legacy TV campaign reached millions of people”
• “renewed our Health Charity Partnership with Tesco, British Heart Foundation and Cancer Research UK through to March 2027”
• “teamed up with Slimming World in a three-year partnership to work together and share expertise on weight loss, healthy eating and diabetes”
• “Over 100 trusts and foundations supported us in 2024, funding a range of ambitious projects”
• “The Drapers' Company chose us as its charity of the year”
• “received £1.4 million from pharmaceutical and medical technology companies in 2024”
• “Abbott's FreeStyle Libre were the headline sponsors of our Glasgow, Birmingham and London Bridges Wellness Walks”
• “London Bridges walk having 5,444 walkers, our biggest number yet!”
• “Funding from Lilly UK and Sanofi enabled us to tackle inequality and stigma through the creation and production of new, easy-to-read materials about living with diabetes”

Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers